Related references
Note: Only part of the references are listed.Ribavirin downmodulates inducible costimulator on CD4+T cells and their interleukin-10 secretion to assist in hepatitis C virus clearance
Masanori Atsukawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
The impact of diabetes on tuberculosis treatment outcomes: A systematic review
Meghan A. Baker et al.
BMC MEDICINE (2011)
'The tubercular diabetic': the impact of diabetes mellitus on tuberculosis and its threat to global tuberculosis control
Sarah Lou Bailey et al.
CLINICAL MEDICINE (2011)
Effect of Type 2 Diabetes Mellitus on the Clinical Severity and Treatment Outcome in Patients With Pulmonary Tuberculosis: A Potential Role in the Emergence of Multidrug-resistance
Jenn-Tyang Chang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2011)
Retention of CD4+ CD25+ FoxP3+ Regulatory T Cells in the Liver after Therapy-Induced Hepatitis C Virus Eradication in Humans
Mark A. A. Claassen et al.
JOURNAL OF VIROLOGY (2011)
The type I interferon system in the etiopathogenesis of autoimmune diseases
Lars Ronnblom
UPSALA JOURNAL OF MEDICAL SCIENCES (2011)
Diabetes mellitus and HIV as co-morbidities in tuberculosis patients of rural south India
Soham Gupta et al.
Journal of Infection and Public Health (2011)
Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes
Rovina Ruslami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Clinical characteristics and evolution of non-HIV-infected immunocompromised patients with an in-hospital diagnosis of tuberculosis
Denise Rossato Silva et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2010)
Tuberculosis Complicating Hepatitis C Treatment in HIV-Infected Patients
Maria Jesus Perez-Elias et al.
CLINICAL INFECTIOUS DISEASES (2009)
Tuberculosis and diabetes mellitus: convergence of two epidemics
Kelly E. Dooley et al.
LANCET INFECTIOUS DISEASES (2009)
Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis
Rod Dawson et al.
PLOS ONE (2009)
An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity
Xiao-Ling Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies
Christie Y. Jeon et al.
PLOS MEDICINE (2008)
Tuberculosis susceptibility of diabetic mice
Gregory W. Martens et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis
Bachti Alisjahbana et al.
CLINICAL INFECTIOUS DISEASES (2007)
Interferon-αβ mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guerin infection
J Kuchtey et al.
IMMUNOLOGY (2006)
IFN-αβ secreted during infection is necessary but not sufficient for negative feedback regulation of IFN-αβ signaling by Mycobacterium tuberculosis
S Prabhakar et al.
JOURNAL OF IMMUNOLOGY (2005)
The Yin and Yang of type I interferon activity in bacterial infection
T Decker et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis
S Yamashiro et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients
R Condos et al.
INFECTION AND IMMUNITY (2003)
IFN-αβ released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10:: Selective recruitment of NK and activated T cells
R Lande et al.
JOURNAL OF IMMUNOLOGY (2003)
Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG
F Bouchonnet et al.
INFECTION AND IMMUNITY (2002)
Share Paper
